BAXTER HLTHCARE CORP Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAXTER HLTHCARE CORP, and what generic alternatives to BAXTER HLTHCARE CORP drugs are available?
BAXTER HLTHCARE CORP has sixty-six approved drugs.
There are twenty US patents protecting BAXTER HLTHCARE CORP drugs. There is one tentative approval on BAXTER HLTHCARE CORP drugs.
There are eight patent family members on BAXTER HLTHCARE CORP drugs in seven countries and one hundred and twenty-four supplementary protection certificates in fourteen countries.
Summary for BAXTER HLTHCARE CORP
International Patents: | 8 |
US Patents: | 20 |
Tradenames: | 78 |
Ingredients: | 52 |
NDAs: | 66 |
Drugs and US Patents for BAXTER HLTHCARE CORP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare Corp | NOURESS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 212535-001 | Dec 13, 2019 | DISCN | Yes | No | 11,642,370 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Baxter Hlthcare Corp | WYAMINE SULFATE | mephentermine sulfate | INJECTABLE;INJECTION | 008248-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Baxter Hlthcare Corp | NOURESS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 212535-001 | Dec 13, 2019 | DISCN | Yes | No | 11,510,941 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Baxter Hlthcare Corp | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ciprofloxacin | INJECTABLE;INJECTION | 078024-001 | Mar 18, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BAXTER HLTHCARE CORP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare Corp | DOXIL (LIPOSOMAL) | doxorubicin hydrochloride | INJECTABLE, LIPOSOMAL;INJECTION | 050718-002 | Jun 13, 2000 | 5,013,556 | ⤷ Sign Up |
Baxter Hlthcare Corp | ZOSYN IN PLASTIC CONTAINER | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 050750-001 | Feb 24, 1998 | 6,900,184 | ⤷ Sign Up |
Baxter Hlthcare Corp | TRANSDERM SCOP | scopolamine | SYSTEM;TRANSDERMAL | 017874-001 | Approved Prior to Jan 1, 1982 | 4,436,741 | ⤷ Sign Up |
Baxter Hlthcare Corp | CLINOLIPID 20% | olive oil; soybean oil | EMULSION;INTRAVENOUS | 204508-001 | Oct 3, 2013 | 5,840,757 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BAXTER HLTHCARE CORP Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2023517926 | ⤷ Sign Up |
Australia | 2021233893 | ⤷ Sign Up |
Canada | 3170514 | ⤷ Sign Up |
European Patent Office | 4117625 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BAXTER HLTHCARE CORP Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2957286 | SPC/GB19/003 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTERED: UK EU/1/17/1179/001(NI) 20170721; UK EU/1/17/1179/002(NI) 20170721; UK EU/1/17/1179/003(NI) 20170721; UK EU/1/17/1179/004(NI) 20170721; UK EU/1/17/1179/005(NI) 20170721; UK EU/1/17/1179/006(NI) 20170721; UK EU/1/17/1179/007(NI) 20170721; UK EU/1/17/1179/008(NI) 20170721; UK EU/1/17/1179/009(NI) 20170721; UK PLGB 50784/0002-0001 20170721; UK PLGB 50784/0003-0001 20170721; UK PLGB 50784/0004-0001 20170721 |
1280520 | 14/2015 | Austria | ⤷ Sign Up | PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720 |
0300652 | 2003C/005 | Belgium | ⤷ Sign Up | PRODUCT NAME: CHLORHYDRATE DE DEXMEDETOMIDINE; REGISTRATION NO/DATE: EU/2/02/033/001 20020903 |
0206283 | SPC/GB97/085 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: LEVOFLOXACIN, OPTIONALLY IN THE FORM OF A HEMIHYDRATE; REGISTERED: UK 13402/0011 19970606; UK 13402/0012 19970606; UK 13402/0013 19970606 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.